We estimate the prevalence and type of urinary incontinence (UI), possible associated risk factors, and the impact of UI on women's social and psychological well-being. The sample consisted of women attending a family medicine clinic at Jordan University Hospital (JUH) who answered a self-administered questionnaire. More than one-third of the sample reported the presence of UI. Stress type was the most frequently reported risk factor, followed by mixed incontinence, then urge. Age, diabetes, chronic cough, parity, and hysterectomy were positively associated with the presence of UI. Incontinence caused low self-esteem in more than half of the women who experienced it.
Metabolic syndrome is being reported more frequently in the Eastern Mediterranean region. Patients with hypertension attending family practice clinics in the University of Jordan Hospital between February and July 2006 were assessed for the frequency of metabolic syndrome and its individual components. Of 345 patients studied, 65% had metabolic syndrome. Females were more likely to meet Adult Treatment Panel-III criteria for the diagnosis. Diabetes mellitus was the most frequent component of metabolic syndrome in males, while low serum high-density lipoprotein cholesterol and high waist circumference ranked first and second in females. Primary care providers should be alert to the importance of screening patients with hypertension for metabolic syndrome to prevent and manage these combined conditions.
This study assessed the prevalence of the metabolic syndrome, and its components, as defined by Adult Treatment Panel III criteria in Jordanian patients attending a family practice clinic for management of cardiovascular risk factors. The sample was 730 randomly selected patients aged ≥ 25 years. The prevalence of metabolic syndrome was 37.4% (31.7% in men; 41.0% in women). The prevalence increased with age in the total sample and in both sexes. High waist circumference showed the highest prevalence in the total sample (61.6%). Among females it ranked as the first criterion (73.5%). High serum triglyceride level showed the highest prevalence in males (50.2%). Differences between the sexes were significant. Family practitioners should be alerted to the importance of multiple risk factors in the metabolic syndrome. Syndrome métabolique en médecine familiale en Jordanie : étude des groupes à haut risque RÉSUMÉ La présente étude a évalué la prévalence du syndrome métabolique et ses composantes selon les critères de l'Adult Treatment Panel III chez des patients jordaniens consultant dans un établissement de soins en médecine familiale pour la prise en charge des facteurs de risque cardio-vasculaires. L'échantillon comprenait 730 patients sélectionnés aléatoirement et âgés d'au moins 25 ans. La prévalence du syndrome métabolique était de 37,4 % (31,7 % chez les hommes ; 41,0 % chez les femmes). Elle augmentait avec l'âge dans l'échantillon total et pour les deux sexes. Une forte prévalence d'un tour de taille élevé a été observée dans l'échantillon total (61,6 %). Chez les femmes, cette mesure était le critère principal (73,5 %). La plus forte prévalence d'une concentration sérique en triglycérides élevée a été observée chez les hommes (50,2 %). Les différences entre les sexes étaient importantes. Les médecins de famille devraient être sensibilisés à l'importance des facteurs de risque multiples pour le syndrome métabolique.
It is clear that there is a need to initiate educational activities and intervention programmes to raise the awareness of health care providers in Jordan regarding pharmacovigilance.
This study aims at assessing the prescription pattern of antihypertensive drugs in hypertensive patients attending the Family Practice Clinics at Jordan University Hospital in
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.